The National Institute on Aging awarded a Project Grant (CFDA 93.866 - Aging Research) totaling $544,163 to Care.coach Corporation to implement and scale the CDC's STEADI fall prevention algorithm using a conversational relational agent for community-dwelling older adults with and without mild cognitive impairment. The project aims to develop and rigorously test a digital STEADI intervention that leverages Care.coach's conversational AI and virtual health assistant platform to screen older...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $407,479 to Senaptec Inc. to develop an in-home sensory training therapy using specialized eyewear ("strobes") to mitigate falls risk among older adults. The project aims to modify the existing strobe design to accommodate prescription lenses and improve functionality in low-light home settings, and to conduct clinical efficacy studies to enable FDA clearance. The goal is to bring this...
This Project Grant award of $835,056, provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports the development of a multi-modal system of wearable biosensors and predictive analytics to enable continuous monitoring of mobility and cognitive function in older adults. The primary goals are to: Develop a system of flexible, breathable, and inconspicuous eutectogel sensor patches that can provide real-time monitoring of biophysical domains like gait, posture, heart rate,...
The National Institute on Aging (NIA) awarded Vigorous Mind, Inc. a $450,000 Project Grant under the Aging Research (CFDA 93.866) federal grant program. The funding supports the development of an autonomous navigating robot equipped with infrared cameras, image processing software, and AI to detect falls and fall risks in nursing home residents with Alzheimer's disease or related dementias. The robot patrols nursing home corridors and rooms to alert staff of incidents, helping address the high...
The National Institute on Aging (NIA) awarded a $858,000 Project Grant (CFDA 93.866 - Aging Research) to the University of Colorado-Denver to evaluate the feasibility of a telehealth-based fall prevention intervention called E-GAPCARE. The goal is to expand the reach of the existing in-person GAPCARE intervention, which has demonstrated a 66% reduction in 6-month fall-related emergency department visits among older adults. The E-GAPCARE project will adapt the GAPCARE protocol for telehealth...
This Project Grant award of $441,032 from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program, awarded on June 15, 2025, supports the development and evaluation of a new auto-calibrated insole system with explainable artificial intelligence (XAI) models. The goal is to enable accurate, tailored, and reliable fall risk assessment for adults aged 65 and older during their normal daily routines. The project aims to address two key hurdles:...
This Project Grant award from the Centers for Disease Control and Prevention's (CDC) Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) provides $794,410 to Kinima, Inc., a women-owned small business, to develop innovative mobile technology solutions focused on fall prevention and mobility improvement for seniors living in subsidized housing. The award supports the research, development, and delivery of an augmented reality-based motion tracking,...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $813,824 focuses on developing innovative, technology-driven strategies for the detection and personalized monitoring of aortic stenosis (AS), a progressive narrowing of the aortic valve that affects older adults. The award supports a multi-center pragmatic randomized controlled trial (RCT) to evaluate a two-stage screening approach using artificial intelligence (AI) applied to...
This federal Project Grant award of $485,192 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports the development of Constantiam Biosciences' MAVEvidence application. MAVEvidence leverages recently-developed multiplexed assays of variant effect (MAVEs) to improve the clinical interpretation of variants in Alzheimer's disease and related dementia (AD/ADRD) risk genes. The project aims to curate and validate MAVE data for key AD/ADRD genes like APP and SNCA,...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Aster Labs, Inc. provides $499,758 to develop an automated system for detecting and reporting lapses in the performance of activities of daily living (ADLs) for individuals with Alzheimer's disease and related dementias. The ActivVerify system will leverage a discreet electronic shoe insole with sensors to automatically and accurately detect and identify ADLs, and then determine and verify...
This Project Grant award of $910,000 from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) supports the development and validation of the AVA AI-powered, video-based mobile application for reliable at-home fall risk assessment of older adults. The project aims to validate the AI and evaluate the feasibility and acceptance of AVA as an effective tool for routine fall risk assessment, targeting both older adults and their caregivers. The key activities include rigorous validation against motion capture systems, user experience research, and usability studies involving 100 diverse older adult participants. This phase I study will lay the groundwork for further development and implementation of the AVA application in phase II and beyond, with the goal of transforming fall risk assessment practices and enhancing quality of life for older adults through increased accessibility and affordability.